Embla Medical to Report Q2 2026 Results on July 21; Conference Call Scheduled
Embla Medical will release its Q2 2026 financial report on July 21, 2026. The company will host a conference call the same day for analysts and investors to discuss the results.
Reykjavik, Iceland/Copenhagen, Denmark – July 7, 2026. Medical device company Embla Medical (Nasdaq Copenhagen: EMBLA) announced today that it will publish its financial report for the second quarter of 2026 on Tuesday, July 21, 2026. The results are scheduled to be released before market open at 7:00 AM CET.
Following the release, the company will host a conference call at 9:00 AM CET / 7:00 AM GMT / 3:00 AM EST on the same day. President and CEO Sveinn Solvason, along with CFO G. Arna Sveinsdottir, will review the quarterly financial results and provide an update on the business. The call will be conducted in English.
Presentation slides used during the call will be made available on the company's investor relations website at www.emblamedical.com/investors following the event. Embla Medical is focused on the development of diagnostic and therapeutic medical devices.
Investors will be reviewing the company's performance for insights into its operational progress and future outlook in the medical device sector.